Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-022704
Filing Date
2024-02-02
Accepted
2024-02-02 13:21:29
Documents
6
Period of Report
2024-02-02

Document Format Files

Seq Description Document Type Size
1 6-K d132037d6k.htm 6-K 9344
2 EX-99.1 d132037dex991.htm EX-99.1 35128
3 EX-99.2 d132037dex992.htm EX-99.2 11108
4 GRAPHIC g132037g0202180941113.jpg GRAPHIC 2601
5 GRAPHIC g132037g73n54.jpg GRAPHIC 1940
6 GRAPHIC g132037g82u48.jpg GRAPHIC 5328
  Complete submission text file 0001193125-24-022704.txt   70831
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 24589948
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)